DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ shed 2.35% to $21.19 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.91% to 44,494.94 and the NASDAQ Composite Index falling 0.82% to 20,202.89.
This was the stock's third consecutive day of losses.
Catalyst Pharmaceuticals Inc. closed 20.28% short of its 52-week high of $26.58, which the company achieved on June 9th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 2.08% to $155.92, Pfizer Inc. $(PFE)$ rose 3.30% to $25.04, and Abbott Laboratories $(ABT)$ rose 0.18% to $136.26.
Trading volume (1.3 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 1, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 01, 2025 17:22 ET (21:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.